hiv grants opportunities 2022
Each year, the federal government commits significant resources to the fight against HIV/AIDS. Visitors are advised to use it at their own discretion. Our Media centre contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information. You may now apply for the next funding cycle of Positive Action Community Grants, which is currently open for organizations in the U.S. and Puerto Rico. Opportunity includes the Dental Services Report (DSR) that applicants use to apply for funding of non- reimbursed costs incurred in providing oral health care to patients with HIV and to report annual program data. NOT-DA-21-019, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) PAR-22-027, Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) RFA-DA-24-001, Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed) RFA-DA-24-008, Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed) RFA-DA-24-009, Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) RFA-DA-24-015, Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) RFA-DA-24-022, Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) RFA-DA-24-023, Notice of Special Interest (NOSI): Pharmacogenomic Approaches to Enhancing HIV and Substance Use Disorder (SUD) Treatment Strategies, A jump into Precision Medicine NOT-DA-24-001, Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) RFA-DA-24-014, Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) RFA-DA-24-013, Notice of Special Interest (NOSI): Research to Address Ending the HIV Epidemic Initiative Goals Relevant to Substance Using Populations At-Risk for or Living with HIV, NOT-DA-23-013, Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) RFA-DA-24-002, Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment, NOT-DA-24-002, Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed) RFA-DA-24-004, Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) RFA-DA-24-003, NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional) RFA-DA-23-061, NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) RFA-DA-23-062, NIDA Program Project Grant Applications (P01 Clinical Trial Optional). CDCs Division of HIV Prevention maintains an HIV Funding and Budget page with information on current CDC HIV prevention funding opportunities open for applicants, as well as active grant programs for which awards have already been made. Learn about these funding programs, as well as about NIH's budget process, grant policies, guidelines, and funding opportunities here. You are about to leave a ViiV Healthcare website. We fund grants to cities, states, counties, and community-based groups to provide HIV care and treatment. We are not responsible for the content on these web sites. We are dedicated to treat, prevent and hopefully one day, cure HIV. From private foundations to corporations seeking to fund grants for nonprofits. The full 2023 Responsive Grants Request for Applications (RFA) can be foundhere, and all accompanying documents and forms can be found below under Forms. This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part A HIV Emergency Relief Grant Program. Funding for Community Based Organizations in South Africa to address HIV and AIDS. Infective endocarditis is a life-threatening inflammation of the heart's chambers and valves that can be difficult and expensive to treat. Centers for Disease Control and Prevention. These cookies may also be used for advertising purposes by these third parties. Rural Health Funding & Opportunities: HIV and AIDS - Rural Health These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Learn about Our Grants. Active OMH Grants - The Office of Minority Health - HHS.gov AWDF particularly encourages organizations led by marginalized and vulnerable groups of women, women living with HIV, and young feminists. 16. VIDEO OF THE EXPO'S OPENING REMARKS IS AVAILABLE HERE WITH ADDITIONAL VIDEO HERE . Wake Forest University School of Divinity | Black Faith & HIV Please contact the funder directly for the most complete and current information. Enter your ZIP code to find HIV testing, PrEP, care and treatment, and other HIV-related services near you. The Chicago Department of Aviation (CDA) hosted its first Airport Expo and Job Fair of 2023 on Wednesday, May 25 at the UIC Forum, 725 W. Roosevelt Rd., for companies and job seekers interested in learning about employment and contracting opportunities at O'Hare and Midway International Airports. The performance measures portfolio focuses on critical areas of HIV care and treatment. Due Dec 14, 2021. CBOs are uniquely positioned to complement and extend the reach of HIV prevention efforts implemented by state and local health departments through the optimization of services across public, private, and other CBOs to achieve objectives of increased HIV diagnoses identification, referral for pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP) services, earlier entry to HIV care, and increased consistency of care. HIV federal funds will reroute to Tennessee nonprofits, state cut out Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) PAR-23-024. United States, https://fundsforngos.org | https://fundsforngospremium.com. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? For details, see Contact Us. We thank you for your interest and for all you do on behalf of people living with HIV and AIDS. PEPFAR UGANDA COMMUNITY GRANTS TO COMBAT HIV/AIDS | Open until May 20, 2022 Under the HOPWA Program, HUD makes grants to local communities, states, and nonprofit organizations for projects that benefit low-income persons living with HIV/AIDS and their families. Contact Us grants@gilead.com | Phone: 650-522-1696 | Fax: 650-522-1707 North America Latin America & the Caribbean Europe View opportunities offered by organizations that provided HIV-related funding. Like hepatitis and HIV, infective endocarditis can be caused by using needles that are not sterile. Thank you for taking the time to confirm your preferences. The Program works with cities, states, and local community-based organizations to provide HIV care and treatment services to more than half a million people each year. Grant Funding | Gilead The funding available for competing and subsequent awards issued under this announcement is subject to the availability of appropriations and budgetary priorities of the Agency. Register early to take advantage of Early Bird Registration rates. General Information about JICA. Visit Apply for a Grant to: Complete mandatory registrations Determine your eligibility Prepare your application Follow the application process Manage Your Grant Read COVID-19 Frequently Asked Questions and visit the Manage Your Grant page to: Attend workshops and access other training Understand administrative and financial requirements They help us to know which pages are the most and least popular and see how visitors move around the site. Topics Communities of Color EHE Ending the HIV Epidemic in the U.S. initiative Funding Funding Opportunities Gay & Bisexual Men Gay & Bisexual Men LGBT Lesbian, Gay, Bisexual, and Transgender NIDA Resources on COVID-19 and Substance Use, Resources to Help Your Patients with SUD During the COVID-19 Pandemic, Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs, Guidance for Potential Applicants of HIV Avant-Garde and Avenir Programs, Office of Research Training, Diversity, and Disparities (ORTDD), Office of Translational Initiatives and Program Innovations (OTIPI), Office of Science Policy and Communications (OSPC), NIDA Avant-Garde Award Program for HIVand Substance Use Disorder Research (DP1, Clinical Trial Optional) PAR-23-269, Avenir Award Program for Research on Substance Use Disorders and HIV(DP2 Clinical Trial Optional) PAR-23-125, High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) RFA-DA-22-040, AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) PAS-21-270, NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) RFA-DA-23-028, NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) RFA-DA-23-029, Notice of Intent to Publish a Funding Opportunity Announcement for Targeting Inflammasomes in Substance Abuse and, Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional) RFA-DA-23-003, Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) PAR-21-310, Imaging - Science Track Award for Research Transition (I/START) (R03 Basic Experimental Studies with Humans Required) PAR-21-309, Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR-19-282, Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) PAR-20-147, Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) PAR-20-148, Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) inSubstance Use Disorder and/or HIV-related processes. In addition to the HIV Plan, the proposed program should be guided by the principles of inclusion of an HIV status neutral approach and addressing social determinants of health and syndemics adversely affecting HIV outcomes in efforts to promote and achieve health equity among the priority populations. Active OMH grants: FY 2022 grants FY 2021 grants FY 2020 grants FY 2019 grants FY 2018 grants FY 2017 grants: . This new funding opportunity announcement is an opportunity to (1) identify drivers of medical mistrust (MM) in Hispanic/Latino (H/L) populations in the United States with special attention to gay, bisexual and other men who have sex with men (HLMSM), and (2) address this social determinant of health by implementing and evaluating multilevel int. All rights reserved. Try out and provide feedback on our beta version of the HIV.gov chatbot, which is still undergoing testing and development prior to its official release. The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) HIV and AIDS Community Grants Program provides direct funding to community based organizations in the districts with the highest HIV burden in South Africa, that are providing services within HIV . The AIDS Drug Assistance Program (ADAP) is a state and territory-administered program authorized under Part B that provides FDA-approved medications to low-income people living with HIV who have limited or no health coverage from private insurance, Medicaid, or Medicare. NOT-DA-21-030, NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) RFA-DA-23-023, NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) RFA-DA-23-024, Stimulants andHIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required). ViiV Healthcare does not recommend, endorse or accept liability for sites controlled by third-parties. Unless otherwise specified, this website is not affiliated with any of the organizations mentioned above. Proposed programs should include the implementation and delivery of strategies and activities that prevent new HIV diagnoses, link clients to HIV prevention and care services, and refer/provide clients to essential support services that aid in reducing HIV-related disparities and health inequities. Funding Opportunities Specific to COVID-19 - grants.nih.gov The IHS is under no . This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under the grant number H89HA00005, CFDA #93.914 HIV Emergency Relief Project Grants, as part of a Fiscal Year 2023 award totaling $27,558,848 as of March 29, 2023, with 0% financed with non-governmental sources. Click here to Get Email Alerts about the Latest Grants. New York, NY 10005 By clicking this link, you will be taken to a website that is independent from ViiV Healthcare. See updated messages from the NIDA HRP scientific leadership team. Important grant programs to pursue outside of emergency funding. Notice of Intent to Publish a Funding Opportunity Announcement for Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track - R44 Clinical Trial Not Allowed) Contact: Orlando Lopez, Ph.D. (301) 402-4243. HIV/AIDS Funding Opportunities | National Institute on Drug Abuse These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Cookies used to make website functionality more relevant to you. What we fund - Elton John AIDS Foundation Search the HIV treatment guidelines, HIV drug database, and medical glossary of HIV-related terms. Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? Secret Discount Link All questions and inquiries should be directed to the ViiV Healthcare Help Desk at viiv@tccgrp.com We thank you for your interest and for all you do on behalf of people living with HIV and AIDS. California. Information on available HUD grants is available here. MFMP is the State of Floridas award-winning eProcurement system in operation for over 15 years. Round-up: 2023 Early Career Grants Programme applications The total funding identified for FY 2022 is approximately $2,480,000. FAQ. Grants for HIV / AIDS supporting general operating expenses. OMH partners with communities and organizations in the public and private sectors to offer financial assistance in support of efforts to eliminate health disparities among racial and ethnic minority populations. Apply for the Future Innovators Summit Tokyo 2018 (Funded) Grants for HIV / AIDS over $5K in average grant size. Since 2020, we have also stepped up support to countries to mitigate the impact of COVID-19 on the HIV response. Infective Endocarditis | National Institute on Drug Abuse (NIDA) Grants for HIV / AIDS by location. Apply for a Grant - AIDS Funding Collaborative Individual award amounts are anticipated to be between $160,000 and $200,000. The agencies and offices within HHS listed below provide grant support for HIV/AIDS prevention, testing, care and treatment, and research. We have once again been amazed by the record number of applications to our Early Career Grants Programme this year - receiving 2,127 applications. Following are commonly used application forms and guidance: AIDS Funding Collaborative 2018 / All Rights Reserved, 2023 Responsive Grant Request for Applications (RFA), 2022 Cover Page Form (for invited applications only), 2022 Responsive Grants Technical Assistance Meeting recordings, Q & A. HIV care and support services, including those aligned with Ryan White categories; Community-led and neighborhood-based HIV programming focused on ZIP codes and networks in greatest need. Where is JICA located, and how can I contact JICA? PAR-22-183, Pathogenic Mechanisms influencing Blood Brain Barrier function in, Notice of NIDA Participation in NOT-MH-21-105, "Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure", Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required) RFA-DA-23-006, Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required) RFA-DA-23-007, Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-20-238, Notice of Special Interest (NOSI): The HIV-HCV-Substance Use Disorder Syndemic: Therapeutic Approaches. The Program is divided into five Parts, each of which provides grant funding to eligible entities. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year 2022 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement high-impact human immunodeficiency virus (HIV) prevention programs in the following two categories: Category A: HIV prevention services for Young Men of Color Who Have Sex with Men (YMSM of color) and their partners regardless of age, gender, and race/ethnicity, Category B: HIV prevention services for Young Transgender Persons of Color (YTG persons of color) and their partners regardless of age, gender, and race/ethnicity.